Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility.
Valeria CalcaterraElvira VerduciHellas CenaVittoria Carlotta MagenesCarolina Federica TodiscoElisavietta TenutaCristina GregorioRachele De GiuseppeAlessandra BosettiElisabetta Di ProfioGian Vincenzo ZuccottiPublished in: Nutrients (2021)
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in young reproductive-aged women. PCOS is often associated with obesity and impairs reproductive health. Even though several theories have been proposed to explain the pathogenic mechanism of PCOS, the role of insulin resistance (IR) as a key etiological component, independently of (but amplified by) obesity, is well recognized. The consequent hyperinsulinemia activates excessive ovarian androgen production, leading to PCOS. Additionally, the state of chronic inflammation related to obesity impacts ovarian physiology due to insulin sensitivity impairment. The first-line treatment for adolescents with obesity and PCOS includes lifestyle changes; personalized dietary interventions; and, when needed, weight loss. Medical nutrition therapy (MNT) and the use of specific food supplements in these patients aim at improving symptoms and signs, including insulin resistance and metabolic and reproductive functions. The purpose of this narrative review is to present and discuss PCOS in adolescents with obesity, its relationship with IR and the role of MNT and food supplements in treatment. Appropriate early dietary intervention for the management of adolescents with obesity and PCOS should be considered as the recommended approach to restore ovulation and to protect fertility.
Keyphrases
- polycystic ovary syndrome
- insulin resistance
- metabolic syndrome
- high fat diet induced
- weight loss
- adipose tissue
- high fat diet
- type diabetes
- skeletal muscle
- physical activity
- young adults
- glycemic control
- randomized controlled trial
- weight gain
- bariatric surgery
- oxidative stress
- healthcare
- depressive symptoms
- stem cells
- mesenchymal stem cells
- end stage renal disease
- pregnant women
- cardiovascular disease
- roux en y gastric bypass
- gastric bypass
- patient reported outcomes
- peritoneal dialysis
- pregnancy outcomes
- cervical cancer screening
- cell therapy